SE7416086L - - Google Patents

Info

Publication number
SE7416086L
SE7416086L SE7416086A SE7416086A SE7416086L SE 7416086 L SE7416086 L SE 7416086L SE 7416086 A SE7416086 A SE 7416086A SE 7416086 A SE7416086 A SE 7416086A SE 7416086 L SE7416086 L SE 7416086L
Authority
SE
Sweden
Prior art keywords
lower alkyl
chain
group
carbon atoms
hydroxy
Prior art date
Application number
SE7416086A
Other versions
SE415763B (en
Inventor
H Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7416086L publication Critical patent/SE7416086L/xx
Publication of SE415763B publication Critical patent/SE415763B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1489088 Aminoketones F HOFFMANN-LA ROCHE & CO AG 20 Dec 1974 [21 Dec 1973] 23143/77 Divided out of 1489086 Heading C2C The invention comprises novel compounds (I) wherein R represents a group of the Formula (Ia) or (Ib) in which R 1 , R 2 and R 3 each represent a hydrogen or halogen atom or a lower alkyl, lower alkoxy, aryl-(lower alkoxy), aryloxy, phenyl, nitro, amino, lower alkylthio, trifluoromethyl, hydroxy, cyano, di(lower alkyl)amino, lower alkanoylamino, carboxyl, lower alkoxycarbonyl, lower alkylsulphonyl, hydroxymethyl, lower alkanoyloxy, amido, lower alkanoyl, sulphamoyl, mono(lower alkyl) sulphamoyl, di(lower alkyl) sulphamoyl, aminocarbonyloxy, mono(lower alkyl) aminocarbonyloxy or (lower alkylamino)-(lower alkyl) group or two adjacent R 1 , R 2 and R 3 symbols together represent a methylenedioxy, ethylenedioxy or butadien- 1,3-ylene-1,4 group, R 4 represents a hydrogen atom or a lower alkyl group, R 5 , R 6 and R 7 each represent a hydrogen or halogen atom or a lower alkyl, lower alkoxy, hydroxy or benzyloxy group or two adjacent R 5 , R 6 and R 7 symbols together represent a methylenedioxy or ethylenedioxy group, Y represents a straight-chain or branched-chain, optionally hydroxy-substituted, aliphatic group containing 2-8 carbon atoms, of which 2-4 carbon atoms are present in the chain, and Z represents a straight-chain or branched-chain, optionally hydroxy-substituted aliphatic group containing 1-8 carbon atoms, of which 1-4 carbon atoms are present in the chain, and m stands for zero or 1, or an acid addition salt thereof; the groups qualified by lower contain up to 6 carbons and aryl signifies phenyl optionally substituted by halogen, lower alkyl, lower alkoxy, NO 2 and amino. The compounds are made by acylating appropriate amines utilizing RCOY.Cl. 3,4 - Dimethoxy - γ - chlorobutyrophenone is made by condensing veratrol and 4-chlorobutyric acid in the presence of polyphosphoric acid.
SE7416086A 1973-12-21 1974-12-19 PROCEDURE FOR THE PREPARATION OF 1,3-DITIOLANYL (2) AND 1,3-DITIANYL (2) SUBSTANCES WITH CORONARDILATING PROPERTIES SE415763B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (2)

Publication Number Publication Date
SE7416086L true SE7416086L (en) 1975-06-23
SE415763B SE415763B (en) 1980-10-27

Family

ID=4429892

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7416086A SE415763B (en) 1973-12-21 1974-12-19 PROCEDURE FOR THE PREPARATION OF 1,3-DITIOLANYL (2) AND 1,3-DITIANYL (2) SUBSTANCES WITH CORONARDILATING PROPERTIES
SE7804879A SE434746B (en) 1973-12-21 1978-04-27 2-PHENYL-M-DITIANDER DERIVATIVES FOR USING INTERMEDIATES WHICH SYNTHESIS OF M-DITIANDER DERIVATIVES WITH CORONARDILATING PROPERTIES

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7804879A SE434746B (en) 1973-12-21 1978-04-27 2-PHENYL-M-DITIANDER DERIVATIVES FOR USING INTERMEDIATES WHICH SYNTHESIS OF M-DITIANDER DERIVATIVES WITH CORONARDILATING PROPERTIES

Country Status (24)

Country Link
JP (1) JPS595594B2 (en)
AT (5) AT344693B (en)
AU (1) AU511714B2 (en)
BE (1) BE823625A (en)
CA (4) CA1057295A (en)
CH (3) CH611614A5 (en)
DD (1) DD116829A5 (en)
DE (2) DE2463173C2 (en)
DK (1) DK148323C (en)
ES (5) ES433172A1 (en)
FI (1) FI67216C (en)
FR (1) FR2255064B1 (en)
GB (3) GB1489088A (en)
HK (1) HK43380A (en)
HU (1) HU170429B (en)
IE (1) IE40788B1 (en)
IL (3) IL46146A (en)
LU (1) LU71530A1 (en)
NL (1) NL158496B (en)
NO (1) NO142669C (en)
PH (3) PH19393A (en)
SE (2) SE415763B (en)
YU (1) YU39311B (en)
ZA (1) ZA747526B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (en) * 1981-10-28 1983-04-29 Delalande Sa 3-Methoxy 4-alkoxy benzaldehyde(s) - useful as intermediates for antibacterials, esp. trimethoprim and tetroxoprim
JPS60142297U (en) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 Rotating device for swiveling driver's seat in forklift
JPS62171328U (en) * 1986-04-23 1987-10-30
DE3642331A1 (en) * 1986-12-11 1988-06-23 Basf Ag BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
MXPA04006344A (en) * 2001-12-28 2005-03-31 Takeda Pharmaceutical Preventives/remedies for urinary disturbance.
WO2010006103A1 (en) * 2008-07-10 2010-01-14 Ore Pharmaceuticals Inc. Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
DE2463173C2 (en) 1987-01-29
IL52843A0 (en) 1977-10-31
GB1489086A (en) 1977-10-19
PH13396A (en) 1980-03-28
CH611614A5 (en) 1979-06-15
HK43380A (en) 1980-08-22
CA1079290A (en) 1980-06-10
IE40788L (en) 1975-06-21
CA1072966A (en) 1980-03-04
SE434746B (en) 1984-08-13
AT350053B (en) 1979-05-10
ES451137A1 (en) 1977-08-16
NL7416507A (en) 1975-06-24
ES451135A1 (en) 1977-08-16
DE2460593A1 (en) 1975-07-03
ZA747526B (en) 1975-12-31
GB1489088A (en) 1977-10-19
ES451136A1 (en) 1977-10-01
ATA38778A (en) 1978-08-15
YU39311B (en) 1984-10-31
DD116829A5 (en) 1975-12-12
NO744615L (en) 1975-07-21
HU170429B (en) 1977-06-28
DE2460593C3 (en) 1979-09-13
FR2255064B1 (en) 1978-03-24
ES451134A1 (en) 1977-08-16
IL52844A0 (en) 1977-10-31
PH13326A (en) 1980-03-13
DK668174A (en) 1975-08-25
AU7600874A (en) 1976-06-03
DE2460593B2 (en) 1979-01-18
FR2255064A1 (en) 1975-07-18
AT344693B (en) 1978-08-10
CA1057295A (en) 1979-06-26
FI352774A (en) 1975-06-22
ATA39178A (en) 1978-08-15
PH19393A (en) 1986-04-07
NO142669B (en) 1980-06-16
BE823625A (en) 1975-06-20
YU336874A (en) 1982-05-31
AU511714B2 (en) 1980-09-04
IE40788B1 (en) 1979-08-15
IL46146A (en) 1980-09-16
DK148323B (en) 1985-06-10
NO142669C (en) 1980-09-24
FI67216C (en) 1985-02-11
DK148323C (en) 1986-03-03
ATA38878A (en) 1978-08-15
JPS5095267A (en) 1975-07-29
AT349013B (en) 1979-03-12
AT349014B (en) 1979-03-12
NL158496B (en) 1978-11-15
SE415763B (en) 1980-10-27
GB1489087A (en) 1977-10-19
AT349012B (en) 1979-03-12
AU3224278A (en) 1978-05-25
CH620921A5 (en) 1980-12-31
JPS595594B2 (en) 1984-02-06
FI67216B (en) 1984-10-31
IL46146A0 (en) 1975-03-13
ATA38978A (en) 1978-10-15
ATA1022674A (en) 1977-12-15
LU71530A1 (en) 1976-11-11
CA1086320A (en) 1980-09-23
CH620920A5 (en) 1980-12-31
ES433172A1 (en) 1977-04-16

Similar Documents

Publication Publication Date Title
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
SE7416086L (en)
GB1315611A (en) Phenylalanine derivatives and a process for the manufacture thereof
GB1455049A (en) Process for the manufacture of 3- 3,4-dihydroxy-phenyl-serine
GB1369249A (en) Amines the preparation thereof and their use in pharmaceutical compositions
GB1483324A (en) Acetylene derivatives
GB1398192A (en) Process for preparing aminonicotinonitriles
GB1334430A (en) Amines and a process for the manufacture thereof
GB1435179A (en) Phthalides and preparation thereof
GB1185618A (en) A Process for the Manufacture of Isoindole Derivatives
GB1394007A (en) Sulphoximines
GB1388180A (en) Acetals
GB1315734A (en) Phenylalanine derivatives and a process for the manufacture thereof
ES8206550A1 (en) 2%-Deoxy-3%,5%-di-O- alkylcarbonyl-5-fluorouridine derivatives, a process for the preparation of the derivatives and anti-tumor agents containing the derivatives
GB1395436A (en) 5,7 disubstituted 1,8 naphthyridin 2 1h-one-8
GB1416415A (en) Biphenyl compounds and their use as light protective agents
FR2374322A1 (en) PROCESS FOR THE PREPARATION OF NEW DERIVATIVES OF PIPERAZINE AND THEIR USE AS VASODILATORS AND ANTI-ARRHYTHMIC PRODUCTS
GB1369580A (en) Tricyclic diphenylamine derivatives
SE7415496L (en)
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
GB1383259A (en) 5-hydroxy-1- -5-substituted phenyl furfurylidene- amino - hydantoins
JPS5266531A (en) Preparation of oxazolylethylene compounds
GB1368470A (en) Antiviral compositions containing bisbasic ketones of dibenzofu ran and methods of treating viruses therewith
GB1442222A (en) Benzodiazepine derivatives
GB1360367A (en) Derivatives of 4,-aminomethyl-dibenzo-b,e- 11-oxepine-2,- spiro- 1,3, -dioxolane their method of preparation and their thera peutic application

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7416086-2

Effective date: 19910704

Format of ref document f/p: F